Lyra Therapeutics Announces $50.0 Million Private Placement

WATERTOWN, Mass., May 26, 2023 -- Lyra Therapeutics, Inc. , a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis, today... | May 26, 2023

Related Keywords

United States ,Ellen Cavaleri ,While The Company ,Lyra Therapeutics Inc ,Company Quarterly Report On Form ,William Blair Company ,Nasdaq ,Cantor Fitzgerald Co ,Hc Wainwright Co ,Globenewswire Inc ,Securities Act ,Private Securities Litigation Reform Act ,Quarterly Report ,Investor Relations ,Lyra Therapeutics ,Nc Stock Exchange ,News ,Information ,Press Release ,Bay ,023 ,Kyra ,Biotechnology ,Company ,Developing ,Nnovative ,Therapies ,Or ,The ,Vocalized ,Treatment ,F ,Hronic Lyra Us55234l1052 ,